During the past decade, Hospital Clínico Universitario de Valencia conducted 465 clinical trials. In the 10-year time frame, 465 clinical trials started and 128 clinical trials were completed, i.e. on average, 27.5% percent of trials that started reached the finish line to date. In the past 5 years, 247 clinical trials started and 99 clinical trials were completed. i.e. 40.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínico Universitario de Valencia" #1 sponsor was "PETHEMA Foundation" with 38 trials, followed by "Boehringer Ingelheim" with 26 trials sponsored, "Spanish Breast Cancer Research Group" with 25 trials sponsored, "Celgene" with 21 trials sponsored and "Fundación para la Investigación del Hospital Clínico de Valencia" with 21 trials sponsored. Other sponsors include 510 different institutions and companies that sponsored additional 252 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínico Universitario de Valencia" #1 collaborator was "Hoffmann-La Roche" with 14 trials as a collaborator, "Pfizer" with 14 trials as a collaborator, "Instituto de Salud Carlos III" with 11 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator and "Eli Lilly and Company" with 10 trials as a collaborator. Other collaborators include 404 different institutions and companies that were collaborators in the rest 282 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínico Universitario de Valencia" are "Breast Cancer" (48 trials), "Multiple Myeloma" (17 trials), "Heart Failure" (14 trials), "Metastatic Breast Cancer" (13 trials) and "Coronary Artery Disease" (11 trials). Many other conditions were trialed in "Hospital Clínico Universitario de Valencia" in a lesser frequency.

Most popular intervention types in "Hospital Clínico Universitario de Valencia" are "Drug" (471 trials), "Other" (67 trials), "Procedure" (39 trials), "Biological" (31 trials) and "Device" (30 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (91 trials), "Carboplatin" (27 trials), "Paclitaxel" (18 trials), "Atezolizumab" (17 trials) and "Cisplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínico Universitario de Valencia" are 561 trials for "All" genders, 76 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 253 active trials in "Hospital Clínico Universitario de Valencia". 2 are not yet recruiting, 144 are recruiting, 104 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 317 completed trials in Hospital Clínico Universitario de Valencia, 1 suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínico Universitario de Valencia, 76 "Phase 1" clinical trials were conducted, 191 "Phase 2" clinical trials and 188 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 49 trials, and there were also 39 trials that are defined as “Not Applicable".

Hospital Clínico Universitario de Valencia has several departments that took part in Clinical trials: "Hospital Clínico Universitario de Valencia; Servicio de Oncología" - 20 trials, "Hospital General Universitario de Elche; Servicio de Oncologia" - 16 trials, "Hospital Universitario La Fe Servicio de Neurología" - 14 trials, "Hospital General Universitario de Valencia; Servicio de oncologia" - 14 trials, "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia" - 10 trials, "Hospital Clinico Universitario de Valencia; Servicio de Neurologia" - 9 trials, "Hospital Universitario Dr. Peset; Servicio de Neurologia" - 9 trials, "Hospital General Universitario de Elche; Servicio de Neurología" - 7 trials, "Hospital General Universitario de Elche" - 195 trials, "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" - 50 trials, "Hospital Universitari i Politècnic La Fe | Cardiología" - 5 trials, "Hospital Universitario la Fe: Servicio de Reumatologia Pediatrica" - 5 trials, "Hospital General Universitario Dr. Balmis" - 4 trials, "Hospital General de Castellon; Servicio de Hematologia" - 4 trials, "Medical Oncology Hospital de Sagunto" - 4 trials, "Hospital Universitario Dr. Peset; Servicio de Hematologia" - 4 trials, "Hospital Virgen de los Lirios; Servicio de Oncologia" - 3 trials, "Hospital General de Elda; Servicio de Oncologia" - 3 trials, "Hospital Arnau de Vilanova (Valencia) Servicio de Hematologia" - 3 trials, "Hospital de Sagunto; Servicio de Oncologia" - 3 trials, "Hospital General Universitario de Alicante; Servicio Cardiologia" - 2 trials, "Hospital Universitario Dr. Peset; Servicio de Nefrologia" - 2 trials, "Hospital General Universitario de Elche Servicio de Farmacia" - 2 trials, "Human Reproduction Unit of the La Fe University and Politechnic Hospital" - 2 trials, "Hospital General Universitario De Valencia; Servicio de Neumologia" - 2 trials